Clinical efficacy of Jianqiao ancient moxibustion in treating chronic fatigue syndrome: a single-center randomized controlled superiority trial protocol - Takeaways - MDSpire

Clinical efficacy of Jianqiao ancient moxibustion in treating chronic fatigue syndrome: a single-center randomized controlled superiority trial protocol

  • By

  • Qimiao Hu

  • Bonuo Qi

  • Yingjun Liu

  • Haijuan Zhang

  • Yulin Liu

  • Yuping Yang

  • Chao Wang

  • June 26, 2026

  • 0 min

Share

  • 1

    Chronic fatigue syndrome (CFS) is a debilitating disorder affecting millions globally, characterized by persistent fatigue and various secondary symptoms.

  • 2

    Traditional Chinese medicine identifies spleen–kidney yang deficiency as the most common syndrome associated with CFS.

  • 3

    This trial will compare the efficacy of Jianqiao ancient moxibustion and conventional moxa box moxibustion in treating CFS.

  • 4

    Ninety patients with CFS will be enrolled in a single-center, single-blind randomized controlled trial over 4 weeks.

  • 5

    Primary and secondary outcomes will include fatigue levels and symptoms related to spleen–kidney yang deficiency, anxiety, and depression.

Original Source(s)

Clinical efficacy of Jianqiao ancient moxibustion in treating chronic fatigue syndrome: a single-center randomized controlled superiority trial protocol

  • by Qimiao Hu, Bonuo Qi, Yingjun Liu, Haijuan Zhang, Yulin Liu, Yuping Yang, Chao Wang

  • June 26, 2026

Related Content

Clinical and high-resolution magnetic resonance imaging–based prediction of ischemic stroke in cervical artery dissection

The liver-brain axis, from its function to preventive therapeutic strategies in diseases

Joint trajectories of sleep quality and cognitive function after acute ischemic stroke: a prospective cohort study using group-based dual trajectory modeling